Jump to content

Definition:Protected cell company (PCC)

From Insurer Brain

🏛️ Protected cell company (PCC) is a single legal entity that is internally divided into a core and multiple ring-fenced "cells," each of which holds its own assets and liabilities that are legally segregated from those of every other cell and from the core. In the insurance and reinsurance industry, PCCs are most commonly used as captive vehicles, special purpose structures for insurance-linked securities, or platforms that allow multiple insureds or sponsors to access the benefits of a captive without forming — and bearing the full cost of — a standalone company. Jurisdictions such as Guernsey (which pioneered the concept), Bermuda, Malta, the Isle of Man, and several U.S. domiciles have enacted specific PCC legislation to give the cell-segregation mechanism statutory force.

⚙️ Each cell within a PCC operates almost as if it were an independent insurer: it can write its own policies, hold its own investment portfolio, maintain its own capital reserves, and produce its own financial results — yet it does so under the umbrella of a single licensed entity managed by a cell-company manager or core sponsor. The critical legal feature is that creditors of one cell generally cannot reach the assets of another cell, which eliminates the cross-contamination risk that would otherwise make shared structures untenable. For a mid-sized company exploring captive insurance, renting a cell within an existing PCC means avoiding the time and expense of obtaining a separate license, appointing its own board, and meeting minimum capital requirements as a standalone entity — while still gaining many of the risk-financing and tax-planning advantages of a captive.

💡 PCCs have expanded beyond traditional captive use into broader market applications. Some MGAs and insurtechs use PCC cells to house specific programs or pilot products, gaining regulated carrier status without building an entire company from scratch. In the ILS space, cells serve as the transformers that convert reinsurance risk into capital-market instruments. Regulators evaluate PCCs by examining both the robustness of the statutory cell-segregation framework and the governance practices of the core entity, since any operational failure at the core level could jeopardize the integrity of all cells. For sponsors and participants alike, the PCC model offers a pragmatic balance of cost efficiency, regulatory access, and asset protection — which explains its steady adoption across the global insurance landscape.

Related concepts: